Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders.

Oetjens MT, Kelly MA, Sturm AC, Martin CL, Ledbetter DH.

Nat Commun. 2019 Oct 25;10(1):4897. doi: 10.1038/s41467-019-12869-0.

2.

Distal chromosome 16p11.2 duplications containing SH2B1 in patients with scoliosis.

Sadler B, Haller G, Antunes L, Bledsoe X, Morcuende J, Giampietro P, Raggio C, Miller N, Kidane Y, Wise CA, Amarillo I, Walton N, Seeley M, Johnson D, Jenkins C, Jenkins T, Oetjens M, Tong RS, Druley TE, Dobbs MB, Gurnett CA.

J Med Genet. 2019 Jul;56(7):427-433. doi: 10.1136/jmedgenet-2018-105877. Epub 2019 Feb 25.

3.

Analysis of the canid Y-chromosome phylogeny using short-read sequencing data reveals the presence of distinct haplogroups among Neolithic European dogs.

Oetjens MT, Martin A, Veeramah KR, Kidd JM.

BMC Genomics. 2018 May 10;19(1):350. doi: 10.1186/s12864-018-4749-z.

4.

Ancient European dog genomes reveal continuity since the Early Neolithic.

Botigué LR, Song S, Scheu A, Gopalan S, Pendleton AL, Oetjens M, Taravella AM, Seregély T, Zeeb-Lanz A, Arbogast RM, Bobo D, Daly K, Unterländer M, Burger J, Kidd JM, Veeramah KR.

Nat Commun. 2017 Jul 18;8:16082. doi: 10.1038/ncomms16082.

5.

Genetic Effects on the Correlation Structure of CVD Risk Factors: Exome-Wide Data From a Ghanaian Population.

Kodaman N, Sobota RS, Asselbergs FW, Oetjens MT, Moore JH, Brown NJ, Aldrich MC, Williams SM.

Glob Heart. 2017 Jun;12(2):133-140. doi: 10.1016/j.gheart.2017.01.013. Epub 2017 Apr 10. Review.

6.

Y-Chromosome Structural Diversity in the Bonobo and Chimpanzee Lineages.

Oetjens MT, Shen F, Emery SB, Zou Z, Kidd JM.

Genome Biol Evol. 2016 Aug 3;8(7):2231-40. doi: 10.1093/gbe/evw150.

7.

Evidence for extensive pleiotropy among pharmacogenes.

Oetjens MT, Bush WS, Denny JC, Birdwell K, Kodaman N, Verma A, Dilks HH, Pendergrass SA, Ritchie MD, Crawford DC.

Pharmacogenomics. 2016 Jun;17(8):853-66. doi: 10.2217/pgs-2015-0007. Epub 2016 Jun 1.

8.

Population Stratification in the Context of Diverse Epidemiologic Surveys Sans Genome-Wide Data.

Oetjens MT, Brown-Gentry K, Goodloe R, Dilks HH, Crawford DC.

Front Genet. 2016 May 6;7:76. doi: 10.3389/fgene.2016.00076. eCollection 2016.

9.

Unravelling the human genome-phenome relationship using phenome-wide association studies.

Bush WS, Oetjens MT, Crawford DC.

Nat Rev Genet. 2016 Mar;17(3):129-45. doi: 10.1038/nrg.2015.36. Epub 2016 Feb 15. Review.

PMID:
26875678
10.

Utilization of an EMR-biorepository to identify the genetic predictors of calcineurin-inhibitor toxicity in heart transplant recipients.

Oetjens M, Bush WS, Birdwell KA, Dilks HH, Bowton EA, Denny JC, Wilke RA, Roden DM, Crawford DC.

Pac Symp Biocomput. 2014:253-64.

11.

Association of the FTO obesity risk variant rs8050136 with percentage of energy intake from fat in multiple racial/ethnic populations: the PAGE study.

Park SL, Cheng I, Pendergrass SA, Kucharska-Newton AM, Lim U, Ambite JL, Caberto CP, Monroe KR, Schumacher F, Hindorff LA, Oetjens MT, Wilson S, Goodloe RJ, Love SA, Henderson BE, Kolonel LN, Haiman CA, Crawford DC, North KE, Heiss G, Ritchie MD, Wilkens LR, Le Marchand L.

Am J Epidemiol. 2013 Sep 1;178(5):780-90. doi: 10.1093/aje/kwt028. Epub 2013 Jul 2.

12.

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.

Perera MA, Cavallari LH, Limdi NA, Gamazon ER, Konkashbaev A, Daneshjou R, Pluzhnikov A, Crawford DC, Wang J, Liu N, Tatonetti N, Bourgeois S, Takahashi H, Bradford Y, Burkley BM, Desnick RJ, Halperin JL, Khalifa SI, Langaee TY, Lubitz SA, Nutescu EA, Oetjens M, Shahin MH, Patel SR, Sagreiya H, Tector M, Weck KE, Rieder MJ, Scott SA, Wu AH, Burmester JK, Wadelius M, Deloukas P, Wagner MJ, Mushiroda T, Kubo M, Roden DM, Cox NJ, Altman RB, Klein TE, Nakamura Y, Johnson JA.

Lancet. 2013 Aug 31;382(9894):790-6. doi: 10.1016/S0140-6736(13)60681-9. Epub 2013 Jun 5.

13.

Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records.

Oetjens MT, Denny JC, Ritchie MD, Gillani NB, Richardson DM, Restrepo NA, Pulley JM, Dilks HH, Basford MA, Bowton E, Masys DR, Wilke RA, Roden DM, Crawford DC.

Pharmacogenomics. 2013 May;14(7):735-44. doi: 10.2217/pgs.13.64.

14.

Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record.

Ramirez AH, Shi Y, Schildcrout JS, Delaney JT, Xu H, Oetjens MT, Zuvich RL, Basford MA, Bowton E, Jiang M, Speltz P, Zink R, Cowan J, Pulley JM, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC.

Pharmacogenomics. 2012 Mar;13(4):407-18. doi: 10.2217/pgs.11.164. Epub 2012 Feb 13.

15.

Predicting clopidogrel response using DNA samples linked to an electronic health record.

Delaney JT, Ramirez AH, Bowton E, Pulley JM, Basford MA, Schildcrout JS, Shi Y, Zink R, Oetjens M, Xu H, Cleator JH, Jahangir E, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC.

Clin Pharmacol Ther. 2012 Feb;91(2):257-63. doi: 10.1038/clpt.2011.221. Epub 2011 Dec 21.

16.

Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin.

Xu H, Jiang M, Oetjens M, Bowton EA, Ramirez AH, Jeff JM, Basford MA, Pulley JM, Cowan JD, Wang X, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC.

J Am Med Inform Assoc. 2011 Jul-Aug;18(4):387-91. doi: 10.1136/amiajnl-2011-000208.

17.

An evolutionary genomic approach to identify genes involved in human birth timing.

Plunkett J, Doniger S, Orabona G, Morgan T, Haataja R, Hallman M, Puttonen H, Menon R, Kuczynski E, Norwitz E, Snegovskikh V, Palotie A, Peltonen L, Fellman V, DeFranco EA, Chaudhari BP, McGregor TL, McElroy JJ, Oetjens MT, Teramo K, Borecki I, Fay J, Muglia L.

PLoS Genet. 2011 Apr;7(4):e1001365. doi: 10.1371/journal.pgen.1001365. Epub 2011 Apr 14.

Supplemental Content

Loading ...
Support Center